B-lymphocyte antigen CD20 epitope peptide fragment, bound to rituximab (Fab fragment). Indications for rituximab include leukemia and lymphoma.
B-lymphocyte antigen CD20 epitope peptide fragment, bound to rituximab (Fab fragment). Indications for rituximab include leukemia, lymphoma and rheumatoid arthritis. 3D rendering based on protein data bank entry 2osl. Cartoon representation with secondary structure coloring (green sheets, red helices). CD20 helices colored blue.
Size: 8000px × 5425px
Photo credit: © molekuul.be / Alamy / Afripics
License: Royalty Free
Model Released: No
Keywords: -cell, -lymphocyte, 20, 3d, acid, amino, antibody, antigen, arthritis, atoms, autoimmune, cancer, cd, cd20, cluster, differentiation, disease, epitope, fab, health, histology, illustration, immunohistochemistry, leukemia, lymphocyte, lymphoma, model, molecular, molecule, monoclonal, ms4a1, pdb_2osl, pemphigus, peptide, polymer, polypeptide, protein, purpura, rendering, rheumatoid, rituximab, science, scientific, structure, surface, thrombocytopenic, vulgaris
